Press Releases MedApp S.A.

Equities

MDA

PLYLWHT00012

End-of-day quote Warsaw S.E. Other stock markets 06:00:00 2024-05-30 pm EDT			5-day change	1st Jan Change
0.322 ^PLN	-2.13%		-2.42%	-6.40%

May. 15	MedApp S.A. Reports Earnings Results for the First Quarter Ended March 31, 2024	CI
Feb. 14	MedApp S.A. Reports Earnings Results for the Fourth Quarter Ended December 31, 2023	CI

Press Releases

Unlock all the news: Be the first to know and act before the market!

100% Free Registration

MedApp S A : launches a subsidiary in the U.S. and opens an office in Orlando!	May. 27	PU
MedApp founder Edwin Hermkens leaves fastest-growing pharmacy in the Netherlands	Feb. 03	AQ
MedApp after Q4 2022: continued development of digital medicine technology solutions and acquisition of new sales contacts	23-02-16	PU
MedApp after Q2 2022: Another Quarter of Geographic and Product Expansion	22-08-15	PU
MedApp S A : reports record results for 2021, doubling both revenue and profits compared to the previous year	22-03-17	PU
MedApp S A : in the OVHcloud Startup Program	22-03-06	PU
MedApp S A : establishes a company in Germany for the DACH market (Germany, Austria, Switzerland)	22-03-01	PU
MedApp S A : receives EU funding to proactively support biopsy performance using holographic visualization of imaging data	22-02-11	PU
MedApp S A : CarnaLife Holo used in cardiac ablation procedure in the best hospital in Poland according to World’s Best Hospitals 2021 ranking	22-02-04	PU
MedApp S A : Development of MedApp SA in 2021	22-02-03	PU
MedApp S A : Mitral valve sealing with MitraClip and CarnaLife Holo	22-01-19	PU
MedApp S A : Tests of the CarnaLife System application in Medicover Poland yield very good results.	21-12-12	PU
MedApp S A : Science fiction becomes reality with technologies developed by the publicly traded company MedApp	21-11-30	PU
MedApp S A : Pre-operative surgical planning to remove the liver and pancreatic cancer lesions using CarnaLifeHolo technology!	21-11-22	PU
MedApp S A : has commenced preparations for FDA certification, Parexel Biotech, a division of Parexel International, has been selected as an advisor	20-07-20	AQ

No results for this search

All News Analyst Reco. Highlights Insiders Transcripts Press Releases Official Publications Other languages Trading Ideas MarketScreener Editorial Features MarketScreener Strategies

Filters

The best tools reserved for subscribers to boost the performance of your investments!

Optimize my profits

fermer